Your Cart ( 1 Item )

• The Safety and Efficacy of Roflumilast Cream 0.15% and 0.05% in Patients With Atopic Dermatitis: Randomized, Double-Blind, Phase 2 Proof of Concept Study
  February 2023 | Volume 22 | Issue 2 | Original Article | 139 | Copyright © February 2023
  Melinda J. Gooderham MS MD^a, Leon H. Kircik MD^b, Matthew Zirwas MD^c, Mark Lee MD^d, Steven E. Kempers MD^e, Zoe D. Draelos MD^f, Laura K. Ferris MD PhD^g, Terry M. Jones MD^h, Etienne Saint-Cyr Proulx MDⁱ, Robert Bissonnette MDⁱ, Neal Bhatia MD^j, Robert A. Koppel MD^k, Scott T. Guenthner MD^lm, Kimmie Eads MSN^m, Howard Welgus MDⁿ, Charlotte Merritt MBAⁿ, Meg Elias BSNⁿ, Lynn Navale MSⁿ, Robert C. Higham MSⁿ, Michael Droege PhDⁿ, David R. Berk MDⁿ
  You will have 48 hours to download the full-text PDF

  Price

  24.95

  Term

  48 Hrs